Poly(A)-containing RNAs with sedimentation coefficients in the range 10-45 S and 10-35 S ( M , 0.2-3.3 x lo6 and 0 . 2 -2 . 2~ lo6 approximately) are present in the nucleus and cytoplasm of T. pyriformis respectively. The poly(A) segments present in both nuclear and cytoplasmic poly(A)-containing RNAs have a chain length of 80-150 nucleotides. Significant amounts of highmolecular-weight poly(A)-containing RNAs (35 s, M , 2.2 x 1 0 6 ) are found in the post-polysomal fraction of the cytoplasm (messenger ribonucleoprotein particles?) and also in large polysomes. In order to exclude the possibility that these high-molecular-weight species are products of nonspecific aggregation, RNA preparations were submitted to severe denaturing conditions before analysis and all electrophoreses were carried out in the presence of 95 % (v/v) formamide.The currently accepted model for mRNA synthesis in eukaryotic cells, proposed by Darnel1 and coworkers [l], involves synthesis of large precursor RNAs in the cell nucleus, post-transcriptional addition of poly(adeny1ic acid) sequences to their 3' termini, reduction of the size of the poly(A)-containing RNAs without loss of the poly(A) segments and transfer of the shortened molecules to the cytoplasm. As required by this model, poly(A) sequences have been found in cytoplasmic and nuclear RNA of mammalian cells [2], and of a variety of lower eukaryotic organisms [ 3 -71. We have previously described several species of nonmethylated cytoplasmic RNA in the unicellular eukaryote, Tetrahymena pyriformis [8], and in subsequent work have found that their RNAs contain poly(A) sequences. In this report we describe how poly(A)-containing RNAs isolated from the nucleus, cytoplasm and polysomes of T. pyriformis have been characterised by electrophoretic analysis under strongly denaturing conditions to avoid aggregation [9,10] and by estimation of the lengths of their poly(A) segments.
MATERIALS AND METHODS
ChemicalsTriethanolamine (analytical grade) and formamide (technical grade) were supplied by Prolabo, France. The latter was purified by fractional distillation in vucuo followed by treatment with Amberlite MB-1 mixed-bed ion-exchange resin (B.D.H., England) according to Pinder et al. [lo]. Acrylamide (Fluka, Switzerland) and N,N'-bisacrylamide (Eastman, Kodak, U.S.A.) were purified by recrystallisation according to Loening [ll]. Cyanogen bromide was supplied by Eastman Kodak, U.S.A., dextran sulfate and Sepharose 4B by Pharmacia, Sweden ; pancreatic RNase, and RNase A by Sigma, U.S.A.; and T1 RNase by Sankyo, Japan. Other products were obtained from Prolabo, France, or Merck, Germany.[S3H]Uridine (spec. act. 20-28 Ci/mmol), and [2-3H]adenine (spec. act. 15 -25 Ci/mmol) were supplied by the Commissariat a 1'Energie Atomique, France.
BuffersBuffer 1 = 10 mM Tris-HC1 pH 7.5,lO mM MgClz, 0.1 M NaC1, 5 pg/ml cycloheximide and 40 pg/ml dextran sulfate. Buffer 2 = 10 mM Tris-HC1 pH 7.6, 0.1 M NaCl, 10 mM EDTA, 0.2% sodium dodecyl sulfate. Buffer 3 = 10 mM Tris-HC1 pH 7.5, 0.36 M NaCl. Buffer 4 = 5...